A nurse is preparing to administer an amphotericin B lipid complex via intermittent IV bolus to a client who has infective endocarditis. Which of the following actions should the nurse take?

A. BUN 15 mg/dL:
Incorrect Explanation: Blood urea nitrogen (BUN) is not a specific marker for assessing the effectiveness of atorvastatin treatment.
Explanation: BUN is a measure of kidney function and the breakdown of protein in the body. It is not directly related to the cholesterol-lowering effects of atorvastatin.
B. LDL 120 mg/dL.
Explanation:
Atorvastatin is a medication used to lower cholesterol levels, particularly low-density lipoprotein (LDL) cholesterol, which is often referred to as "bad" cholesterol. Elevated LDL cholesterol levels are a risk factor for cardiovascular disease. The goal of using medications like atorvastatin is to reduce LDL cholesterol levels to a target range, as recommended by healthcare guidelines.
A lower LDL cholesterol level indicates that the treatment with atorvastatin has been effective in achieving the desired therapeutic goal of lowering cholesterol levels and reducing the risk of cardiovascular events. Therefore, a decrease in LDL cholesterol is a positive outcome of atorvastatin therapy.
C. Urine specific gravity 1.020:
Incorrect Explanation: Urine-specific gravity is not a marker for assessing the effectiveness of atorvastatin.
Explanation: Urine-specific gravity measures the concentration of urine and is related to hydration status and kidney function. It is not used to evaluate the effectiveness of cholesterol-lowering medications like atorvastatin.
D. Blood glucose 90 mg/dL:
Incorrect Explanation: A blood glucose level of 90 mg/dL is not indicative of the effectiveness of atorvastatin treatment.
Explanation: Blood glucose level measures the amount of sugar in the bloodstream and is unrelated to the cholesterol-lowering effects of atorvastatin.

A. The nurse who identifies the error:
This choice is correct. When a medication error is identified, the nurse who discovers the error is responsible for completing an incident report. Incident reports are a formal way to document any unexpected or adverse events that occur in a healthcare setting, including medication errors. The report helps track incidents, analyze their causes, and implement preventive measures. It's important for the reporting nurse to provide accurate and detailed information about the error.

B. The Quality Improvement Committee:
This choice is incorrect. While the Quality Improvement (QI) Committee plays a role in analyzing trends, identifying areas for improvement, and developing strategies to enhance patient care quality, they are not typically responsible for completing individual incident reports. The responsibility for reporting and documenting a specific incident, such as a medication error, lies with the staff members directly involved.

C. The charge nurse:
This choice is incorrect. The charge nurse is responsible for overseeing the nursing unit's operations, including staffing and patient care coordination. While the charge nurse may be involved in addressing the situation and ensuring appropriate actions are taken following a medication error, they are not necessarily responsible for completing the incident report. The reporting responsibility usually falls on the nurse who identifies the error.

D. The nurse who caused the error:
This choice is incorrect. While it's important for the nurse who caused the error to communicate the error to appropriate parties and participate in any necessary corrective actions, the primary responsibility for completing the incident report usually lies with the nurse who identifies the error. The reporting nurse's perspective is crucial for understanding the context and details of the error.